Registry of Lobbyists
Version 1 of 42 (2007-04-25 to 2007-05-01) was submitted prior to the Lobbying Act coming into force on July 2, 2008. Due to different information requirements at that time, the registration is presented in the following format.
| Corporation: |
Abbott Laboratories, Limited
8401 Transcanada Highway St-Laurent, QC H4S 1Z1 Canada |
| Telephone number: | 514-832-7429 |
| Fax number: | 514832 7865 |
| Responsible officer name and position during the period of this registration: | Jeffrey Devlin, Director, Government & External Affairs |
| Description of activities: | Abbott is a broad-based health care company that discovers, develops, manufactures and markets products that span the continuum of care - from prevention and diagnosis to treatment and cure. Abbott's principal businesses include medical products, including devices, diagnostic tests and instruments, nutritionals for children and adults, and pharmaceuticals. |
| The client is a subsidiary of the following parent companies: |
Abbott Laboratories
100 Abbott Park Rd Abbott Park, IL United States of America 60064-3500 |
| Coalition | The corporation is not a member of a coalition. |
| Subsidiary: | The corporation does not have any subsidiaries that could be affected by the outcome of the undertaking. |
| Other direct interests | The corporation's activities are not controlled or directed by another individual, organization or corporation with a direct interest in the outcome of this undertaking. |
| Was the corporation funded in whole or in part by any domestic or foreign government institution in the last completed financial year? | No |
| Name: | Martin Cloutier |
| Position title: | Regulatory Affairs, Project Manager |
| Public offices held: | No |
| Name: | Loretta Del Bosco |
| Position title: | Director, Regulatory Affairs & Quality Assurance |
| Public offices held: | No |
| Name: | Jeffrey Devlin |
| Position title: | President and General Manager |
| Public offices held: | No |
| Name: | Laurie Dotto |
| Position title: | Director Government & External Affairs |
| Public offices held: | No |
| Name: | Claire Ducharme |
| Position title: | Regulatory Affairs Specialist |
| Public offices held: | No |
| Name: | France Guertin |
| Position title: | Regulatory Affairs, Project Manager |
| Public offices held: | No |
| Name: | Christine Kor |
| Position title: | Regulatory Affairs Associate |
| Public offices held: | No |
| Name: | Michelle LeBlanc |
| Position title: | Drug Safety & Regulatory Compliance Manager |
| Public offices held: | Yes |
| Name: | David Link |
| Position title: | National Manager Market Access & Governmental Affairs |
| Public offices held: | No |
| Name: | Judith Mergl |
| Position title: | Senior Manager Regulatory Affairs |
| Public offices held: | No |
| Name: | Scott Oke |
| Position title: | Provincial Affairs Manager |
| Public offices held: | No |
| Name: | Diana Pappas |
| Position title: | Safety Officer |
| Public offices held: | No |
| Name: | Diana Parison |
| Position title: | Senior Manager Market Access Planning & HE |
| Public offices held: | No |
| Name: | Danielle Rochon |
| Position title: | Safety Officer |
| Public offices held: | No |
| Name: | Shady William |
| Position title: | Regulatory Affairs Associate |
| Public offices held: | No |
| Name: | Andrew Wynn |
| Position title: | Provincial Affairs Manager |
| Public offices held: | No |
| Federal departments or organizations which have been or will be communicated with during the course of the undertaking: | Aboriginal Affairs and Northern Development Canada, Correctional Service of Canada (CSC), Health Canada (HC), Immigration and Refugee Board (IRB), National Defence (DND), Patented Medicine Prices Review Board (PMPRB), Public Service Health Care Plan, Public Works and Government Services Canada, Royal Canadian Mounted Police (RCMP), Veterans Affairs Canada (VAC) | ||||
|
Communication techniques that have been used or are expected to be used in the course of the undertaking:
|
Meetings, Telephone calls, Written communications, whether in hard copy or electronic format | ||||
| Subject Matter: Areas of Concern: | Health, Industry, Intellectual Property, R&D, Regulatory, Science and Technology, Taxation and Finance, Trade | ||||
| Subject Matter: Retrospective: | Communications in relation to:- Commenting on proposed Health Canada policies and guidelines.- National Pharmaceutical Strategy - Cross border trade / Internet Pharmacies - Common Drug Review - Patented Medicine Prices Review Board (PMPRB) (pricing)- Canada's Innovation Strategy (Science & Technology, Research & Development) Canada's Access to Medicine Regime (Jean Chretien Drugs for Africa bill) | ||||
| Subject Matter: Prospective: | Communications in relation to:- Commenting on proposed Health Canada policies and guidelines.- Interacting with Health Canada to challenge proposed changes to the Non Insured Health Benefits (NIHB) for Proton Pump Inhibitors.- National Pharmaceutical Strategy- Cross border trade / Internet Pharmacies- Common Drug Review- PMPRB (pricing)- Canada's Innovation Strategy (Science & Technology, Research & Development)- Canada's Access to Medicine Regime (Jean Chretien Drugs for Africa bill) | ||||
Details Regarding the Identified Subject Matter
|
|||||